Fractyl HEALTH, Inc. (GUTS) intrinsic value & 10-year financials
Fractyl HEALTH, Inc. (GUTS) has a Graham intrinsic value of $58.57 per share. At $1.55 on Oct 17, 2026, the stock trades 97% below that value. Over the last 4 fiscal years revenue shrank 22.5% a year to $0, with an average return on invested capital of -2147.1%.
- Graham intrinsic value
- $58.57
- Share price (Oct 17, 2026)
- $1.55
- Price vs Graham value
- 97% below
- Market cap
- $117.5M
- Revenue (FY2025)
- $0
- Revenue growth (4-yr CAGR)
- -22.5%
- ROIC (10-yr avg)
- -2147.1%
- Free cash flow (FY2025)
- -$90.9M
GUTS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $0 | -$141.0M | -$1.86 | -$90.9M | — | -6532.8% |
| FY2024 | $93.0K | -$68.7M | -$1.62 | -$67.3M | -100571.0% | 73.0% |
| FY2023 | $120.0K | -$77.1M | -$2.26 | -$43.2M | -42363.3% | 18.5% |
| FY2022 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
FRACTYL HEALTH, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
FRACTYL HEALTH, INC. returns on capital have been average, hovering around 8.7% ROIC over the decade.
FRACTYL HEALTH, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, FRACTYL HEALTH, INC. is modeled at -22.5% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $58.57 per share.